AltMountain

Blackstone Life Sciences V L.P.

New York, NY · CIK 1797712
Status: no Form D since Jul 2020. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Blackstone Life Sciences V L.P. is a private equity fund based in New York, New York. According to its most recent Form D, filed Jul 9, 2020, it has sold $4,605,000,000 of interests to 102 investors since its first sale in Dec 2019. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include John Finley; Christopher Striano; Nick Galakatos.

Total raised
$4,605,000,000Cumulative sales reported on Form D
Investors
102
First sale
Dec 31, 2019
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
John Finley; Christopher Striano; Nick Galakatos
Latest Form D
Jul 9, 2020

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction

Raise history

$4,605,000,000Jan 9, 2020: $3,444,130,000 raisedFeb 7, 2020: $3,444,130,000 raisedMay 13, 2020: $4,202,370,000 raisedJul 9, 2020: $4,605,000,000 raisedJan 2020Jul 2020
FiledFilingTotal raisedInvestorsSource
Jul 9, 2020Form D/A (amendment)$4,605,000,000102SEC.gov ↗
May 13, 2020Form D/A (amendment)$4,202,370,00099SEC.gov ↗
Feb 7, 2020Form D/A (amendment)$3,444,130,00086SEC.gov ↗
Jan 9, 2020Form D$3,444,130,00086SEC.gov ↗

4 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jan 9, 2020. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Vehicles of this fund (2)

Legal name on Form DSEC CIKLocation reportedTotal raisedInvestorsMinimumLatest Form D
Blackstone Life Sciences V L.P. (main vehicle on this page)1797712New York, New York$4,605,000,000102$0Jul 9, 2020
Blackstone Life Sciences V (Lux) SCSp1797872New York, New York$4,605,000,00020$0Jul 9, 2020

Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings carry the same name apart from such vehicle words or a series letter and report the same location or the same adviser, so AltMountain shows them on one page; the details above are those of Blackstone Life Sciences V L.P., the vehicle reporting the most raised. Each row is that vehicle's own filing, exactly as filed. The amounts should not be added together, because a feeder's money can also be counted in its master fund. Grouped by AltMountain from the filings; not confirmed by the fund. The CIK links open each vehicle's filings on SEC.gov. Source: SEC Form D filings.

Raise history: Blackstone Life Sciences V (Lux) SCSp

FiledFilingTotal raisedInvestorsSource
Jul 9, 2020Form D/A (amendment)$4,605,000,00020SEC.gov ↗
Jan 9, 2020Form D$3,444,130,0008SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jan 9, 2020. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Blackstone Life Sciences V L.P.

What is the minimum investment for Blackstone Life Sciences V L.P.?

Blackstone Life Sciences V L.P.'s latest Form D, filed Jul 9, 2020, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Blackstone Life Sciences V L.P.?

Blackstone Life Sciences V L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Blackstone Life Sciences V L.P. raised?

Blackstone Life Sciences V L.P. reports $4,605,000,000 sold from 102 investors on its Form D filed Jul 9, 2020. This is cumulative sales since the offering began, not current assets or performance.

Where is Blackstone Life Sciences V L.P. based?

Blackstone Life Sciences V L.P. is based in New York, New York.

When did Blackstone Life Sciences V L.P. launch?

Blackstone Life Sciences V L.P. reports its first sale in Dec 2019.

Size compared with every private equity fund

Raised more than 99% of the 3,669 private equity funds based in New York, and more than 99% of all 8,950 that report sales.

Other funds with the same team

More private equity funds in New York

Similar-size private equity funds in New York

All private equity funds in New York